Ionis Pharmaceuticals, Inc. (IONS) Social Stream



Ionis Pharmaceuticals, Inc. (IONS): $44.09

-0.19 (-0.43%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

IONIS PHARMACEUTICALS INC (IONS) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering IONS.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 13 $68 $20 $46.045 $43.46 5.95%
2021-12-07 13 $68 $20 $45.409 $43.46 4.48%
2021-12-08 13 $68 $22 $45.318 $43.46 4.28%
2021-12-28 13 $68 $22 $45.136 $43.46 3.86%
2022-01-21 13 $68 $22 $44.681 $43.46 2.81%
2022-02-24 13 $68 $22 $43.772 $43.46 0.72%
2022-02-28 13 $68 $22 $43.136 $43.46 -0.75%
2022-03-01 15 $68 $22 $43.591 $43.46 0.3%
2022-03-07 14 $68 $22 $42.125 $43.46 -3.07%
2022-03-24 13 $68 $22 $41.708 $43.46 -4.03%
2022-03-31 14 $68 $22 $42.653 $43.46 -1.86%
2022-04-13 14 $68 $22 $42.423 $43.46 -2.39%
2022-05-04 14 $68 $22 $42.115 $43.46 -3.09%
2022-06-13 13 $68 $22 $42.666 $43.46 -1.83%
2022-08-03 13 $68 $22 $42.916 $43.46 -1.25%
2022-08-04 13 $68 $22 $43.333 $43.46 -0.29%
2022-08-10 14 $68 $22 $44.923 $43.46 3.37%
2022-08-13 14 $68 $22 $46 $43.46 5.84%
2022-08-16 14 $68 $22 $45.923 $43.46 5.67%

The Trend in the Analyst Price Target


Over the past 168 days, IONS's average price target has gone up $0.49.

Over the past 49 weeks, IONS's average upside potential has been 22.52%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-12-08 13 68 22 45.318 32.21 40.7%
2022-02-01 13 68 22 43.772 31.51 38.91%
2022-03-01 14 68 22 42.125 34.08 23.61%
2022-03-01 14 68 22 43.591 34.08 27.91%
2022-04-29 14 68 22 42.115 36.76 14.57%

IONS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.52 5 2 3 2 2 14

The Trend in the Broker Recommendations


IONS's average broker recommendation rating improved by 0.07 over the prior 122 days.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, IONIS PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 200% of them.
  • In the context of all US stocks, IONIS PHARMACEUTICALS INC's variance in analysts' estimates is lower than -1966.82% of them.
  • In terms of how IONIS PHARMACEUTICALS INC fares relative to Pharmaceutical Products stocks, note that its number of analysts covering the stock is higher than 2055.91% of that group.
  • To contextualize these metrics, consider that out of stocks in the large market cap category, IONIS PHARMACEUTICALS INC's average analyst price target is higher than 534.15% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to IONIS PHARMACEUTICALS INC are HZNP, GSK, and GRFS.

Is IONS a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5243 seconds.